#Supply Chain Resilience
Explore articles tagged with Supply Chain Resilience
Can Asset-Light Manufacturing Make Pharma Capacity Expansion Faster, More Flexible & Scalable? | Siliconindia
Hari Kiran Chereddi, Founder, MD & CEO, HRV Pharma, explores how asset-light manufacturing can help pharmaceutical companies build greater flexibility, scalability and efficiency into their manufacturing strategies.
The New Growth Blueprint for APIs | BW Healthcare World
The API industry is rethinking how manufacturing capacity and supply chains are structured, with manufacturing networks offering a more resilient approach through qualified partners, regulatory ownership and greater visibility.
Trust Isn't a Feeling. It's a System.
How can a pharmaceutical company maintain quality without owning its manufacturing plants? HRV Pharma builds trust through standardised audits, real-time performance tracking and continuous visibility across 53 partners, helping identify issues before they become shipment or regulatory problems.